J&J and Boston University identify classifications to catch lung cancer

J&J, Boston University find markers to intercept lung cancer before it manifests

J&J and Boston University identified a subtype of precancerous lesions with genomic alterations and immune cell deficiencies that could be used to diagnose and stratify patients at the earliest stages of lung cancer.

The findings, revealed in a Nature Communications paper Tuesday, are the first published

Read the full 452 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE